Table 2.
Demography and vestibular function tests of patients with bilateral vestibulopathy.
| Patient | Gender | Age | Etiology | Duration (months) | Caloric test | vHIT | RC | DVA | DHI | VDRL | HADS | MMSE | GDS | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RW | RC | LW | LC | RT | LT | Rt VOR gain | Lt VOR gain | ||||||||||||
| 1 | F | 68 | Idiopathic (severe DM) | 240 | 0 | 0 | 0 | 0 | 0 | 0 | 0.65 | 0.6 | 0.01 | + | 78 | 131 | – | 24 | 28 |
| 2 | M | 62 | Recurrent bilateral VN | 300 | 0 | 2 | 0 | 2 | 2 | 2 | 0.93 | 0.25 | 0.06 | − | 4 | 27 | 8 | 29 | 5 |
| 3 | F | 49 | Ototoxic (gentamicin) | 3 | 4.4 | 3.6 | 2.2 | 6.3 | 8.0 | 8.5 | 0.72 | 0.52 | 0.1 | − | 46 | 99 | 19 | 30 | 29 |
| 4 | F | 59 | Idiopathic (post-OP) | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.64 | 0.65 | 0.05 | + | 62 | 61 | 23 | 30 | 13 |
| 5 | M | 67 | Recurrent bilateral VN | 120 | 3 | 3 | 0 | 0 | 6.0 | 0 | 0.83 | 0.66 | 0.03 | + | 46 | 46 | – | 28 | 17 |
| 6 | M | 71 | Idiopathic (post-OP) | 4 | 0 | 0 | 1.9 | 1.2 | 0 | 3.1 | 0.57 | 0.52 | 0.04 | + | 56 | 69 | 25 | 29 | 24 |
| 7 | M | 63 | Head trauma | 22 | 3.8 | 2.4 | 4.4 | 4.8 | 6.2 | 9.2 | 0.71 | 0.56 | 0.1 | − | 50 | 42 | 20 | 29 | 24 |
| 8 | F | 67 | Idiopathic (DM, CKD5) | 18 | 0 | 0 | 0 | 0 | 0 | 0 | 0.35 | 0.36 | 0.04 | + | 76 | 141 | 23 | 24 | 23 |
| 9 | F | 22 | SLE | 3 | 1.4 | 5.9 | 6.9 | 3.2 | 7.3 | 10.1 | 0.34 | 0.39 | – | + | 94 | 152 | 16 | 30 | 19 |
| 10 | M | 80 | Recurrent bilateral VN | 4 | 1.7 | 0 | 1.1 | 0 | 1.7 | 1.1 | 0.65 | 0.34 | 0.2 | + | 62 | 134 | 17 | 28 | 15 |
| 11 | M | 75 | AML, ototoxic | 3 | 1.1 | 2 | 2.2 | 0 | 3.2 | 2.2 | 0.54 | 0.5 | – | + | 46 | 136 | 9 | 25 | 8 |
| 12 | F | 68 | Idiopathic | 180 | 0.6 | 0 | 0 | 0.4 | 0.6 | 0.4 | 0.72 | 0.53 | – | + | 54 | 53 | 24 | 27 | 22 |
| 13 | F | 74 | Idiopathic (post-OP) | 36 | 3.4 | 1.3 | 1.7 | 2.3 | 4.7 | 4.0 | 0.48 | 0.54 | 0.04 | + | 82 | 114 | 18 | 24 | 13 |
| Mean | 63.46 | 72.00 | 1.49 | 1.55 | 1.57 | 1.55 | 2.59 | 3.12 | 0.63 | 0.50 | 58.15 | 92.69 | 27.46 | 18.46 | |||||
| SD | 14.70 | 103.755 | 1.63 | 1.84 | 2.09 | 2.09 | 3.00 | 3.74 | 0.17 | 0.12 | 22.47 | 44.34 | 2.40 | 7.42 | |||||
| Range (min–max) | 22–80 | 3–300 | 0–4.40 | 0–5.9 | 0–6.9 | 0–6.3 | 0–8.0 | 0–10.1 | 0.34–0.93 | 0.25–0.66 | 4–94 | 27–152 | 24–30 | 5–28 | |||||
RW, right warm stimulation; RC, right cold stimulation; LW, left warm stimulation; LC, left cold stimulation; RT, right total summation (RW + RC); LT, left total summation (LW + LC); vHIT, video-head impulse test; VOR, vestibulo-ocular reflex; RC, rotatory chair test; DVA, dynamic visual acuity; DHI, dizziness handicap inventory score; VDRL, vestibular disorders activities of daily living scale; HADS, hospital anxiety and depression scale; DM, diabetes mellitus; VN, vestibular neuritis; OP, operation; CKD, stage 5 chronic kidney disease; SLE, systemic lupus erythematosus; AML, acute myeloid leukemia; MMSE, mini-mental state examination; GDS, geriatric depression scale.